Please login to the form below

Not currently logged in
Email:
Password:

Bruce Peacock joins Dicerna from Ophthotech

He is appointed to its board of directors and audit committee

edit-Bruce-Peacock_2014US-based biopharma company Dicerna Pharmaceuticals has appointed Bruce Peacock to its board of directors and audit committee.

He joins from Ophthotech where he served since 2010, most recently as its chief financial and business officer and prior to that, his previous roles include serving as chief operating officer of Cephalon and chief financial officer of Centocor.

Massachusetts-headquartered Dicerna develops RNAi-based therapeutics with a focus on the discovery and development of treatments for rare inherited diseases involving the liver and for cancers that are genetically defined.

Douglas Fambrough, CEO at Dicerna, said: “Bruce Peacock is a recognised leader in the biotech industry. With an impressive list of accomplishments in operations, management and business development, Bruce will be a terrific addition to our board.”

22nd September 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics